MedPath

Exercise Following Autologous Peripheral Blood Stem Cell Transplantation

Phase 3
Conditions
Hematological Disease
Interventions
Other: Supervised exercise
Registration Number
NCT00883961
Lead Sponsor
Charite University, Berlin, Germany
Brief Summary

The study evaluates the effects of a supervised exercise program on the physical performance, the mood and the complications of therapy in patients undergoing a high-dose chemotherapy followed by an autologous peripheral blood stem cell transplantation.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Age 18-70
  • Hematological disease
  • Treatment with high-dose chemotherapy followed by autologous stem cell transplantation
  • Understanding of written German
Exclusion Criteria
  • Cardiorespiratory, metabolical, osteoarticular or immunological diseases which can be aggravated by exercise
  • Pathological stress-ECG at admission

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Supervised exerciseSupervised exercise-
Primary Outcome Measures
NameTimeMethod
VO2maxAt recruitment and after 3 weeks
Secondary Outcome Measures
NameTimeMethod
MoodAt recruitment and after 3 weeks
Duration of aplasia3 weeks
Complications during hospitalization3 weeks
Need for transfusion of platelets and red blood cells3 weeks

Trial Locations

Locations (1)

Section Sports Medicine, Charité Universitätsmedizin Berlin, Hindenburgdamm 30

🇩🇪

Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath